- Home
- VANI vs NCSM Comparison
VANI vs NCSM Comparison
Compare VANI & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- NCSM
- Stock Information
- Founded
- VANI 1998
- NCSM 2006
- Country
- VANI United States
- NCSM United States
- Employees
- VANI N/A
- NCSM N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NCSM Oilfield Services/Equipment
- Sector
- VANI Health Care
- NCSM Energy
- Exchange
- VANI Nasdaq
- NCSM Nasdaq
- Market Cap
- VANI 65.2M
- NCSM 61.1M
- IPO Year
- VANI 2014
- NCSM 2017
- Fundamental
- Price
- VANI $1.02
- NCSM $36.62
- Analyst Decision
- VANI Strong Buy
- NCSM
- Analyst Count
- VANI 1
- NCSM 0
- Target Price
- VANI $4.00
- NCSM N/A
- AVG Volume (30 Days)
- VANI 107.5K
- NCSM 20.0K
- Earning Date
- VANI 05-12-2025
- NCSM 04-30-2025
- Dividend Yield
- VANI N/A
- NCSM N/A
- EPS Growth
- VANI N/A
- NCSM N/A
- EPS
- VANI N/A
- NCSM 2.55
- Revenue
- VANI N/A
- NCSM $162,557,000.00
- Revenue This Year
- VANI N/A
- NCSM $7.03
- Revenue Next Year
- VANI N/A
- NCSM $5.82
- P/E Ratio
- VANI N/A
- NCSM $14.04
- Revenue Growth
- VANI N/A
- NCSM 14.10
- 52 Week Low
- VANI $1.00
- NCSM $15.35
- 52 Week High
- VANI $2.22
- NCSM $37.74
- Technical
- Relative Strength Index (RSI)
- VANI 34.58
- NCSM 63.63
- Support Level
- VANI $1.06
- NCSM $32.96
- Resistance Level
- VANI $1.16
- NCSM $37.69
- Average True Range (ATR)
- VANI 0.04
- NCSM 2.42
- MACD
- VANI -0.00
- NCSM 0.28
- Stochastic Oscillator
- VANI 12.50
- NCSM 90.17
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.